Cartalax is a research peptide supplied by Badger Compounds for laboratory use only and is not intended for human or animal consumption.

Cartalax Peptide

Overview

Cartalax is a synthetic tripeptide bioregulator supplied by Badger Compounds for laboratory use only. This research peptide, with the sequence Ala-Glu-Asp (AED), is studied in cartilage, connective tissue, and cellular aging research models.

The peptide belongs to the family of short regulatory peptides associated with the Khavinson research program. Its ultrashort three-amino-acid structure is frequently selected as a low-complexity tool for studying tissue-specific cellular regulation.

Researchers incorporate Cartalax into fibroblast and connective tissue models examining proliferation, extracellular matrix regulation, and senescence-related markers in vitro. Its documented sequence supports reproducible experimental design.

Every lot of Cartalax from Badger Compounds is characterized to a purity of ≥99% (HPLC) and verified by independent third-party analytical testing, supporting consistent research conditions.

Cartalax Peptide Mechanism of Action (Research Context)

In published research models, Cartalax is studied as a short regulatory peptide proposed to interact with DNA-associated targets in the cell nucleus. Reports describe associations with the expression of proliferation markers and modulation of apoptosis-related signaling in connective tissue cells.

These observations are examined in the context of fibroblast activity, extracellular matrix remodeling, and cellular senescence in laboratory systems. The proposed tissue-specific behavior of bioregulator peptides remains an active area of investigation. All described observations are confined to in vitro and preclinical research settings and do not represent clinical outcomes.

Additional Research Considerations

Investigators evaluating this peptide often review the broader bioregulator and connective tissue biology literature to contextualize their findings. A current overview of relevant publications can be found through the PubMed database, which indexes peer-reviewed studies describing short regulatory peptides in experimental systems.

Research Applications

• Investigation of fibroblast proliferation and apoptosis-related signaling in vitro
• Studies of extracellular matrix regulation in connective tissue models
• Cellular senescence and aging research in controlled laboratory environments
• Reference standard work alongside related bioregulator research peptides
• Method development for analytical detection of short regulatory peptides

Product Specifications

• Form: Lyophilized powder
• Purity: ≥99% (HPLC)
• Quantity: 20 mg per vial (single vial and 10-vial options)
• Molecular Weight: 333.29 Da
• Molecular Formula: C12H19N3O8
• Sequence: Ala-Glu-Asp (AED tripeptide)
• CAS Number: Not formally assigned (synthetic bioregulator peptide)
• Solubility: Soluble in water for laboratory preparation
• Characterization: Identity and purity confirmed by HPLC and mass spectrometry
• Testing: Independent third-party analytical verification

Storage and Handling

Lyophilized Cartalax should be stored at -20°C and protected from light and moisture. Once reconstituted in a laboratory setting, the solution is best kept refrigerated at 2°C to 8°C and used within a short working window. Handling should follow standard laboratory safety practices, including the use of appropriate personal protective equipment. This material is intended for qualified research personnel only.

Related Research Compounds

Laboratories studying bioregulator peptides and cellular aging frequently pair Cartalax with related research peptides such as Epitalon and Pinealon. Browse the full longevity and cellular aging catalog for additional compounds.

Frequently Asked Questions

What is Cartalax?
Cartalax is a synthetic AED tripeptide bioregulator studied in cartilage, connective tissue, and cellular aging research. It is supplied strictly as a research peptide for laboratory use.

What purity is this Cartalax?
Each lot is characterized to ≥99% (HPLC) purity and confirmed through independent third-party testing.

How should Cartalax be stored?
Store the lyophilized powder at -20°C away from light and moisture, and refrigerate any reconstituted solution prepared in the laboratory.

Disclaimer

This product is intended for laboratory and research use only. It is not a drug, food, cosmetic, or dietary supplement, and it is not intended to diagnose, treat, cure, or prevent any disease. It is not for human or veterinary use or consumption in any form. All information provided is for educational and research purposes only and does not constitute medical advice. By purchasing, the buyer confirms they are a qualified researcher or institution and accepts full responsibility for safe handling, use, and disposal in compliance with applicable laws and regulations.